Artículos de revistas
Ligand- and Structure-Based Drug Design Strategies and PPAR delta/alpha Selectivity
Fecha
2012Registro en:
Chemical Biology & Drug Design, Hoboken, v. 80, n. 4, supl. 4, Part 1-2, pp. 533-544, oct, 2012
1747-0277
10.1111/j.1747-0285.2012.01424.x
Autor
Maltarollo, Vinicius G.
Honorio, Káthia Maria
Institución
Resumen
Peroxisome-proliferator-activated receptors are a class of nuclear receptors with three subtypes: a, ? and d. Their main function is regulating gene transcription related to lipid and carbohydrate metabolism. Currently, there are no peroxisome-proliferator-activated receptors d drugs being marketed. In this work, we studied a data set of 70 compounds with a and d activity. Three partial least square models were created, and molecular docking studies were performed to understand the main reasons for peroxisome-proliferator-activated receptors d selectivity. The obtained results showed that some molecular descriptors (log P, hydration energy, steric and polar properties) are related to the main interactions that can direct ligands to a particular peroxisome-proliferator-activated receptors subtype.